Clinical Trials Browser

Phase 2 × OTHER × Salivary Gland Malignancy × Clear all

NCT01634880 2016-05-23

Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

Phase 2 Withdrawn

Salivary Gland Malignancy